Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Magnitude and Quality of Cytokine and Chemokine Storm during Acute Infection Distinguish Nonprogressive and Progressive Simian Immunodeficiency Virus Infections of Nonhuman Primates.

Keating SM, Heitman JW, Wu S, Deng X, Stacey AR, Zahn RC, de la Rosa M, Finstad SL, Lifson JD, Piatak M Jr, Gauduin MC, Kessler BM, Ternette N, Carville A, Johnson RP, Desrosiers RC, Letvin NL, Borrow P, Norris PJ, Schmitz JE.

J Virol. 2016 Oct 28;90(22):10339-10350. doi: 10.1128/JVI.01061-16. Print 2016 Nov 15.

2.

Postnatal acquisition of primary rhesus cytomegalovirus infection is associated with prolonged virus shedding and impaired CD4+ T lymphocyte function.

Antoine P, Varner V, Carville A, Connole M, Marchant A, Kaur A.

J Infect Dis. 2014 Oct 1;210(7):1090-9. doi: 10.1093/infdis/jiu215. Epub 2014 Apr 8.

3.

Use of OpdA, an organophosphorus (OP) hydrolase, prevents lethality in an African green monkey model of acute OP poisoning.

Jackson CJ, Carville A, Ward J, Mansfield K, Ollis DL, Khurana T, Bird SB.

Toxicology. 2014 Mar 20;317:1-5. doi: 10.1016/j.tox.2014.01.003. Epub 2014 Jan 18.

4.

Characterization of circulating natural killer cells in neotropical primates.

Carville A, Evans TI, Reeves RK.

PLoS One. 2013 Nov 11;8(11):e78793. doi: 10.1371/journal.pone.0078793. eCollection 2013.

5.

Resistance to infection, early and persistent suppression of simian immunodeficiency virus SIVmac251 viremia, and significant reduction of tissue viral burden after mucosal vaccination in female rhesus macaques.

Manrique M, Kozlowski PA, Cobo-Molinos A, Wang SW, Wilson RL, Martinez-Viedma Mdel P, Montefiori DC, Carville A, Aldovini A.

J Virol. 2014 Jan;88(1):212-24. doi: 10.1128/JVI.02523-13. Epub 2013 Oct 23.

6.

Mucosal immunization of lactating female rhesus monkeys with a transmitted/founder HIV-1 envelope induces strong Env-specific IgA antibody responses in breast milk.

Fouda GG, Amos JD, Wilks AB, Pollara J, Ray CA, Chand A, Kunz EL, Liebl BE, Whitaker K, Carville A, Smith S, Colvin L, Pickup DJ, Staats HF, Overman G, Eutsey-Lloyd K, Parks R, Chen H, Labranche C, Barnett S, Tomaras GD, Ferrari G, Montefiori DC, Liao HX, Letvin NL, Haynes BF, Permar SR.

J Virol. 2013 Jun;87(12):6986-99. doi: 10.1128/JVI.00528-13. Epub 2013 Apr 17.

7.

Immunogenicity of a vaccine regimen composed of simian immunodeficiency virus DNA, rMVA, and viral particles administered to female rhesus macaques via four different mucosal routes.

Manrique M, Kozlowski PA, Cobo-Molinos A, Wang SW, Wilson RL, Montefiori DC, Carville A, Aldovini A.

J Virol. 2013 Apr;87(8):4738-50. doi: 10.1128/JVI.03531-12. Epub 2013 Feb 13.

8.

In vivo anti-HIV activity of the heparin-activated serine protease inhibitor antithrombin III encapsulated in lymph-targeting immunoliposomes.

Asmal M, Whitney JB, Luedemann C, Carville A, Steen R, Letvin NL, Geiben-Lynn R.

PLoS One. 2012;7(11):e48234. doi: 10.1371/journal.pone.0048234. Epub 2012 Nov 2.

9.

ADCC develops over time during persistent infection with live-attenuated SIV and is associated with complete protection against SIV(mac)251 challenge.

Alpert MD, Harvey JD, Lauer WA, Reeves RK, Piatak M Jr, Carville A, Mansfield KG, Lifson JD, Li W, Desrosiers RC, Johnson RP, Evans DT.

PLoS Pathog. 2012;8(8):e1002890. doi: 10.1371/journal.ppat.1002890. Epub 2012 Aug 23.

10.

In vivo selection of CD4(+) T cells transduced with a gamma-retroviral vector expressing a single-chain intrabody targeting HIV-1 tat.

Braun SE, Taube R, Zhu Q, Wong FE, Murakami A, Kamau E, Dwyer M, Qiu G, Daigle J, Carville A, Johnson RP, Marasco WA.

Hum Gene Ther. 2012 Sep;23(9):917-31. doi: 10.1089/hum.2011.184.

11.

Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primates.

Mire CE, Miller AD, Carville A, Westmoreland SV, Geisbert JB, Mansfield KG, Feldmann H, Hensley LE, Geisbert TW.

PLoS Negl Trop Dis. 2012;6(3):e1567. doi: 10.1371/journal.pntd.0001567. Epub 2012 Mar 20.

12.

Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys.

Barouch DH, Liu J, Li H, Maxfield LF, Abbink P, Lynch DM, Iampietro MJ, SanMiguel A, Seaman MS, Ferrari G, Forthal DN, Ourmanov I, Hirsch VM, Carville A, Mansfield KG, Stablein D, Pau MG, Schuitemaker H, Sadoff JC, Billings EA, Rao M, Robb ML, Kim JH, Marovich MA, Goudsmit J, Michael NL.

Nature. 2012 Jan 4;482(7383):89-93. doi: 10.1038/nature10766.

13.

Durable mucosal simian immunodeficiency virus-specific effector memory T lymphocyte responses elicited by recombinant adenovirus vectors in rhesus monkeys.

Li H, Liu J, Carville A, Mansfield KG, Lynch D, Barouch DH.

J Virol. 2011 Nov;85(21):11007-15. doi: 10.1128/JVI.05346-11. Epub 2011 Sep 14.

14.

Gut inflammation and indoleamine deoxygenase inhibit IL-17 production and promote cytotoxic potential in NKp44+ mucosal NK cells during SIV infection.

Reeves RK, Rajakumar PA, Evans TI, Connole M, Gillis J, Wong FE, Kuzmichev YV, Carville A, Johnson RP.

Blood. 2011 Sep 22;118(12):3321-30. doi: 10.1182/blood-2011-04-347260. Epub 2011 Jul 26.

15.

Antibodies to lytic infection proteins in lymphocryptovirus-infected rhesus macaques: a model for humoral immune responses to epstein-barr virus infection.

Orlova N, Fogg MH, Carville A, Wang F.

Clin Vaccine Immunol. 2011 Sep;18(9):1427-34. doi: 10.1128/CVI.05126-11. Epub 2011 Jul 6.

16.

High cell-free virus load and robust autologous humoral immune responses in breast milk of simian immunodeficiency virus-infected african green monkeys.

Wilks AB, Perry JR, Ehlinger EP, Zahn RC, White R, Gauduin MC, Carville A, Seaman MS, Schmitz JE, Permar SR.

J Virol. 2011 Sep;85(18):9517-26. doi: 10.1128/JVI.00796-11. Epub 2011 Jul 6.

17.

International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations.

Barouch DH, Kik SV, Weverling GJ, Dilan R, King SL, Maxfield LF, Clark S, Ng'ang'a D, Brandariz KL, Abbink P, Sinangil F, de Bruyn G, Gray GE, Roux S, Bekker LG, Dilraj A, Kibuuka H, Robb ML, Michael NL, Anzala O, Amornkul PN, Gilmour J, Hural J, Buchbinder SP, Seaman MS, Dolin R, Baden LR, Carville A, Mansfield KG, Pau MG, Goudsmit J.

Vaccine. 2011 Jul 18;29(32):5203-9. doi: 10.1016/j.vaccine.2011.05.025. Epub 2011 May 25.

18.

Extended safety and efficacy studies of a live attenuated double leucine and pantothenate auxotroph of Mycobacterium tuberculosis as a vaccine candidate.

Sampson SL, Mansfield KG, Carville A, Magee DM, Quitugua T, Howerth EW, Bloom BR, Hondalus MK.

Vaccine. 2011 Jun 24;29(29-30):4839-47. doi: 10.1016/j.vaccine.2011.04.066. Epub 2011 May 5.

19.

Long-term control of simian immunodeficiency virus mac251 viremia to undetectable levels in half of infected female rhesus macaques nasally vaccinated with simian immunodeficiency virus DNA/recombinant modified vaccinia virus Ankara.

Manrique M, Kozlowski PA, Cobo-Molinos A, Wang SW, Wilson RL, Montefiori DC, Mansfield KG, Carville A, Aldovini A.

J Immunol. 2011 Mar 15;186(6):3581-93. doi: 10.4049/jimmunol.1002594. Epub 2011 Feb 11.

20.

Quantification of mucosal mononuclear cells in tissues with a fluorescent bead-based polychromatic flow cytometry assay.

Reeves RK, Evans TI, Gillis J, Wong FE, Connole M, Carville A, Johnson RP.

J Immunol Methods. 2011 Mar 31;367(1-2):95-8. doi: 10.1016/j.jim.2011.02.002. Epub 2011 Feb 18.

21.

Cryptosporidiosis in rhesus macaques challenged during acute and chronic phases of SIV infection.

Singh I, Carville A, Tzipori S.

AIDS Res Hum Retroviruses. 2011 Sep;27(9):989-97. doi: 10.1089/AID.2010.0229. Epub 2011 Mar 27.

22.

SIV-specific CD8+ T cells are enriched in female genital mucosa of rhesus macaques and express receptors for inflammatory chemokines.

Cromwell MA, Carville A, Mansfield K, Klumpp S, Westmoreland SV, Lackner AA, Johnson RP.

Am J Reprod Immunol. 2011 Mar;65(3):242-7. doi: 10.1111/j.1600-0897.2010.00966.x. Epub 2011 Jan 12.

23.

Robust vaccine-elicited cellular immune responses in breast milk following systemic simian immunodeficiency virus DNA prime and live virus vector boost vaccination of lactating rhesus monkeys.

Wilks AB, Christian EC, Seaman MS, Sircar P, Carville A, Gomez CE, Esteban M, Pantaleo G, Barouch DH, Letvin NL, Permar SR.

J Immunol. 2010 Dec 1;185(11):7097-106. doi: 10.4049/jimmunol.1002751. Epub 2010 Nov 1.

24.

Envelope-modified single-cycle simian immunodeficiency virus selectively enhances antibody responses and partially protects against repeated, low-dose vaginal challenge.

Alpert MD, Rahmberg AR, Neidermyer W, Ng SK, Carville A, Camp JV, Wilson RL, Piatak M Jr, Mansfield KG, Li W, Miller CJ, Lifson JD, Kozlowski PA, Evans DT.

J Virol. 2010 Oct;84(20):10748-64. doi: 10.1128/JVI.00945-10. Epub 2010 Aug 11.

25.

Mucosal trafficking of vector-specific CD4+ T lymphocytes following vaccination of rhesus monkeys with adenovirus serotype 5.

Masek-Hammerman K, Li H, Liu J, Abbink P, La Porte A, O'Brien KL, Whitney JB, Carville A, Mansfield KG, Barouch DH.

J Virol. 2010 Oct;84(19):9810-6. doi: 10.1128/JVI.01157-10. Epub 2010 Aug 4.

26.

Low-dose mucosal simian immunodeficiency virus infection restricts early replication kinetics and transmitted virus variants in rhesus monkeys.

Liu J, Keele BF, Li H, Keating S, Norris PJ, Carville A, Mansfield KG, Tomaras GD, Haynes BF, Kolodkin-Gal D, Letvin NL, Hahn BH, Shaw GM, Barouch DH.

J Virol. 2010 Oct;84(19):10406-12. doi: 10.1128/JVI.01155-10. Epub 2010 Aug 4.

27.

Colorectal cancer in the cotton top tamarin (Saguinus oedipus): how do they evade liver metastasis?

Tobi M, Kim M, Zimmer R, Hatfield J, Kam M, Khoury N, Carville A, Lawson MJ, Schiemann WP, Thomas P.

Dig Dis Sci. 2011 Feb;56(2):397-405. doi: 10.1007/s10620-010-1314-2. Epub 2010 Jul 20.

28.

Pharmacokinetics of OpdA, an organophosphorus hydrolase, in the African green monkey.

Jackson CJ, Scott C, Carville A, Mansfield K, Ollis DL, Bird SB.

Biochem Pharmacol. 2010 Oct 1;80(7):1075-9. doi: 10.1016/j.bcp.2010.06.008. Epub 2010 Jun 23.

29.

Limited contribution of mucosal IgA to Simian immunodeficiency virus (SIV)-specific neutralizing antibody response and virus envelope evolution in breast milk of SIV-infected, lactating rhesus monkeys.

Permar SR, Wilks AB, Ehlinger EP, Kang HH, Mahlokozera T, Coffey RT, Carville A, Letvin NL, Seaman MS.

J Virol. 2010 Aug;84(16):8209-18. doi: 10.1128/JVI.00656-10. Epub 2010 Jun 2.

30.

Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys.

Santra S, Liao HX, Zhang R, Muldoon M, Watson S, Fischer W, Theiler J, Szinger J, Balachandran H, Buzby A, Quinn D, Parks RJ, Tsao CY, Carville A, Mansfield KG, Pavlakis GN, Felber BK, Haynes BF, Korber BT, Letvin NL.

Nat Med. 2010 Mar;16(3):324-8. doi: 10.1038/nm.2108. Epub 2010 Feb 21.

31.

Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys.

Barouch DH, O'Brien KL, Simmons NL, King SL, Abbink P, Maxfield LF, Sun YH, La Porte A, Riggs AM, Lynch DM, Clark SL, Backus K, Perry JR, Seaman MS, Carville A, Mansfield KG, Szinger JJ, Fischer W, Muldoon M, Korber B.

Nat Med. 2010 Mar;16(3):319-23. doi: 10.1038/nm.2089. Epub 2010 Feb 21.

32.

Glycoprotein gene sequence variation in rhesus monkey rhadinovirus.

Shin YC, Jones LR, Manrique J, Lauer W, Carville A, Mansfield KG, Desrosiers RC.

Virology. 2010 May 10;400(2):175-86. doi: 10.1016/j.virol.2010.01.030. Epub 2010 Feb 20.

33.

Suppression of adaptive immune responses during primary SIV infection of sabaeus African green monkeys delays partial containment of viremia but does not induce disease.

Zahn RC, Rett MD, Li M, Tang H, Korioth-Schmitz B, Balachandran H, White R, Pryputniewicz S, Letvin NL, Kaur A, Montefiori DC, Carville A, Hirsch VM, Allan JS, Schmitz JE.

Blood. 2010 Apr 15;115(15):3070-8. doi: 10.1182/blood-2009-10-245225. Epub 2010 Feb 10.

34.

Local replication of simian immunodeficiency virus in the breast milk compartment of chronically-infected, lactating rhesus monkeys.

Permar SR, Kang HH, Wilks AB, Mach LV, Carville A, Mansfield KG, Learn GH, Hahn BH, Letvin NL.

Retrovirology. 2010 Feb 1;7:7. doi: 10.1186/1742-4690-7-7.

35.

Alopecia in Rhesus macaques correlates with immunophenotypic alterations in dermal inflammatory infiltrates consistent with hypersensitivity etiology.

Kramer J, Fahey M, Santos R, Carville A, Wachtman L, Mansfield K.

J Med Primatol. 2010 Apr;39(2):112-22. doi: 10.1111/j.1600-0684.2010.00402.x. Epub 2010 Jan 20.

36.

Preservation of memory CD4(+) T lymphocytes in breast milk of lactating rhesus monkeys during acute simian immunodeficiency virus infection.

Permar SR, Kang HH, Carville A, Wilks AB, Mansfield KG, Rao SS, Letvin NL.

J Infect Dis. 2010 Jan 15;201(2):302-10. doi: 10.1086/649229.

37.

Nasal DNA-MVA SIV vaccination provides more significant protection from progression to AIDS than a similar intramuscular vaccination.

Manrique M, Kozlowski PA, Wang SW, Wilson RL, Micewicz E, Montefiori DC, Mansfield KG, Carville A, Aldovini A.

Mucosal Immunol. 2009 Nov;2(6):536-50. doi: 10.1038/mi.2009.103. Epub 2009 Sep 9.

PMID:
19741603
38.

A New World primate deficient in tetherin-mediated restriction of human immunodeficiency virus type 1.

Wong SK, Connole M, Sullivan JS, Choe H, Carville A, Farzan M.

J Virol. 2009 Sep;83(17):8771-80. doi: 10.1128/JVI.00112-09. Epub 2009 Jun 24.

39.

Protective efficacy of a single immunization of a chimeric adenovirus vector-based vaccine against simian immunodeficiency virus challenge in rhesus monkeys.

Barouch DH, Liu J, Lynch DM, O'Brien KL, La Porte A, Simmons NL, Riggs AM, Clark S, Abbink P, Montefiori DC, Landucci G, Forthal DN, Self SG, Carville A, Mansfield K, Goudsmit J.

J Virol. 2009 Sep;83(18):9584-90. doi: 10.1128/JVI.00821-09. Epub 2009 Jun 24.

40.

Interleukin-18 predicts atherosclerosis progression in SIV-infected and uninfected rhesus monkeys (Macaca mulatta) on a high-fat/high-cholesterol diet.

Yearley JH, Xia D, Pearson CB, Carville A, Shannon RP, Mansfield KG.

Lab Invest. 2009 Jun;89(6):657-67. doi: 10.1038/labinvest.2009.29. Epub 2009 Apr 20.

41.

Recombinant Mycobacterium bovis BCG prime-recombinant adenovirus boost vaccination in rhesus monkeys elicits robust polyfunctional simian immunodeficiency virus-specific T-cell responses.

Cayabyab MJ, Korioth-Schmitz B, Sun Y, Carville A, Balachandran H, Miura A, Carlson KR, Buzby AP, Haynes BF, Jacobs WR, Letvin NL.

J Virol. 2009 Jun;83(11):5505-13. doi: 10.1128/JVI.02544-08. Epub 2009 Mar 18.

42.

Evidence behind the WHO guidelines: hospital care for children: what is the evidence that BCG vaccination should not be used in HIV-infected children?

Bannister C, Bennett L, Carville A, Azzopardi P.

J Trop Pediatr. 2009 Apr;55(2):78-82. doi: 10.1093/tropej/fmp018. Epub 2009 Mar 10. Review. No abstract available.

PMID:
19276146
43.

Immunization with single-cycle SIV significantly reduces viral loads after an intravenous challenge with SIV(mac)239.

Jia B, Ng SK, DeGottardi MQ, Piatak M, Yuste E, Carville A, Mansfield KG, Li W, Richardson BA, Lifson JD, Evans DT.

PLoS Pathog. 2009 Jan;5(1):e1000272. doi: 10.1371/journal.ppat.1000272. Epub 2009 Jan 23.

44.

Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys.

Liu J, O'Brien KL, Lynch DM, Simmons NL, La Porte A, Riggs AM, Abbink P, Coffey RT, Grandpre LE, Seaman MS, Landucci G, Forthal DN, Montefiori DC, Carville A, Mansfield KG, Havenga MJ, Pau MG, Goudsmit J, Barouch DH.

Nature. 2009 Jan 1;457(7225):87-91. doi: 10.1038/nature07469. Epub 2008 Nov 9.

45.

Rhesus lymphocryptovirus type 1-associated B-cell nasal lymphoma in SIV-infected rhesus macaques.

Marr-Belvin AK, Carville AK, Fahey MA, Boisvert K, Klumpp SA, Ohashi M, Wang F, O'Neil SP, Westmoreland SV.

Vet Pathol. 2008 Nov;45(6):914-21. doi: 10.1354/vp.45-6-914.

46.

The efficacy of T cell-mediated immune responses is reduced by the envelope protein of the chimeric HIV-1/SIV-KB9 virus in vivo.

Stevceva L, Yoon V, Carville A, Pacheco B, Santosuosso M, Korioth-Schmitz B, Mansfield K, Poznansky MC.

J Immunol. 2008 Oct 15;181(8):5510-21.

47.

Trafficking of antigen-specific CD8+ T lymphocytes to mucosal surfaces following intramuscular vaccination.

Kaufman DR, Liu J, Carville A, Mansfield KG, Havenga MJ, Goudsmit J, Barouch DH.

J Immunol. 2008 Sep 15;181(6):4188-98.

48.

Potent simian immunodeficiency virus-specific cellular immune responses in the breast milk of simian immunodeficiency virus-infected, lactating rhesus monkeys.

Permar SR, Kang HH, Carville A, Mansfield KG, Gelman RS, Rao SS, Whitney JB, Letvin NL.

J Immunol. 2008 Sep 1;181(5):3643-50.

49.

DNA-MVA vaccine protection after X4 SHIV challenge in macaques correlates with day-of-challenge antiviral CD4+ cell-mediated immunity levels and postchallenge preservation of CD4+ T cell memory.

Manrique M, Micewicz E, Kozlowski PA, Wang SW, Aurora D, Wilson RL, Ghebremichael M, Mazzara G, Montefiori D, Carville A, Mansfield KG, Aldovini A.

AIDS Res Hum Retroviruses. 2008 Mar;24(3):505-19. doi: 10.1089/aid.2007.0191.

50.

SV40 infection associated with rituximab treatment after kidney transplantation in nonhuman primates.

Maki T, Carville A, Stillman IE, Sato K, Kodaka T, Minamimura K, Ogawa N, Kanamoto A, Gottschalk R, Monaco AP, Marr-Belvin A, Westmoreland SV, Sehgal P.

Transplantation. 2008 Mar 27;85(6):893-902. doi: 10.1097/TP.0b013e3181668ecc.

PMID:
18360273

Supplemental Content

Loading ...
Support Center